MetaVia Inc. Ordinary Shares MTVA 深 沪
等待开盘 11-06 09:30:00 美东时间
1.1109
+0.031
+2.86%
华盛通- 最 高1.35
- 今 开1.20
- 成交量 1831.83万股
- 最 低 1.0701
- 昨 收 1.08
- 总市值 2688.13万
- 52周最高 2.75
- 市盈率 静 --
- 换手率 75.70%
- 52周最低 0.5555
- 委 比 42.48%
- 总股本 2419.78万
- 历史最高 138900.00
- 量 比 326.50
- 振 幅 25.92%
- 历史最低 0.5555
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MetaVia To Present New Phase 1 And Pre-clinical Data On DA-1726 In Two Poster Presentations At ObesityWeek 2025; New Phase 1 PK Data Support Once-Weekly Dosing; Clinically Meaningful Weight Loss Observed Without Dose Titration
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, a novel, dual
11-05 05:28
MetaVia To Present Vanoglipel Data For MASH At AASLD, Highlighting Hepatoprotective And Metabolic Effects
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a novel
10-27 20:43
MetaVia Announces Poster Presentations on DA-1726 at ObesityWeek® 2025
CAMBRIDGE, Mass., Oct. 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that two...
10-20 20:31
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Pre...
10-14 20:31
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Shares of Webtoon Entertainment Inc (NASDAQ:WBTN) rose sharply in pre-market tr...
09-16 17:41
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock rose 25.5% to $2.66 during Monday's afte...
09-16 05:06
HC Wainwright & Co. Assumes MetaVia at Buy, Announces Price Target of $12
HC Wainwright & Co. analyst Andrew S. Fein assumes MetaVia (NASDAQ:MTVA) with a Buy rating and announces Price Target of $12.
09-04 19:28
MetaVia Highlights Clinical Trials and Future Plans
The latest announcement is out from MetaVia ( ($MTVA) ). On August 7, 2025, Met...
08-08 05:48
MetaVia Q2 EPS $(0.26) Beats $(0.31) Estimate
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 85.95 percent increase over losses of $(1.85) per share from the same
08-07 20:34
MetaVia Partners with Syntekabio for DA-1241 Research
The latest announcement is out from MetaVia ( ($MTVA) ). On August 4, 2025, Met...
08-04 21:19
